Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 4Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Prostatic Neoplasms 2Mouth Neoplasms 2Congenital Abnormalities 2Carcinoma, Non-Small-Cell Lung 2Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Prostate Adenocarcinoma 1Papillomavirus Infections 1Pancreatic Neoplasms 1Osteoporosis 1Oropharyngeal Neoplasms 1Obesity 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Melanoma 1Malignant mesenchymal tumor 1Lymphoma, Mantle-Cell 1Lymphoma 1Lung Neoplasms 1Liposarcoma 1

Interventions

Dexamethasone 276Lenalidomide 154Bortezomib 152Cyclophosphamide 115Melphalan 107Calcium Dobesilate 107fludarabine phosphate 70carfilzomib 60pomalidomide 55Peripheral Blood Stem Cell Transplantation 53Whole-Body Irradiation 52Mycophenolic Acid 52Granulocyte Colony-Stimulating Factor 52Filgrastim 52daratumumab 45fludarabine 43Tacrolimus 41ixazomib 40Busulfan 40Thalidomide 36Cyclosporine 32dexamethasone acetate 26Stem Cell Transplantation 26Antilymphocyte Serum 25dexamethasone 21-phosphate 22plerixafor 20auricularum 20belantamab mafodotin 19Prednisone 19Etoposide 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Multiple Myeloma × Observation × Clear all
NCT00075829 2021-11-01

BMT CTN 0102

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
710 enrolled 19 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡